Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Earnings Scheduled For January 31, 2025
Tickers ABBV ALV AON ARCB
Tags VRTS NVS BZI/UE
From Benzinga
AbbVie Vs. Novartis: Which Has The Technical Edge Before Q4 Earnings?
Tickers ABBV NVS
Tags Technicals pharmaceuticals NVS
From Benzinga
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
Tickers ABBV AZN CI CNC
Tags drug prices ABBV Politics
From Benzinga
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Tickers AMGN AZN BMY CYTK
Tags JNJ AMGN Stories That Matter
From Benzinga
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
Tickers CRSP GOOGL LLY NEWS
Tags News LLY benzinga neuro
From Benzinga
Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug
Tickers NEWS NVS OTLK RHHBY
Tags Top Stories News Offerings
From Benzinga
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development
Tickers NEWS NVS SLDB SRPT
Tags Analyst Ratings Biotech NVS
From Benzinga
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
Tickers AMRX CVS NEWS NVS
Tags NVS AMRX VTRS
From Benzinga
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Tickers GS LLY MRK NVDA
Tags Recent Press Releases NVS LLY
From Motley Fool
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Tickers BMY CI CNC CVS
Tags HQY IHF JNJ
From Benzinga
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Tickers AMGN AZN BMY EXEL
Tags Market News General Briefs
From Benzinga
Novartis Touts Encouraging Data From Late-Stage Study For Fabhalta In Rare Type Of Blood Disorder
Tickers AZN NEWS NVS PTCT
Tags Market News Briefs General
From Benzinga
Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst
Tickers JANX NEWS NVS
Tags Analyst Color Expert Ideas News
From Benzinga
PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program
Tickers NEWS NVS PTCT
Tags News Briefs General
From Benzinga
2 Dividend Stocks to Buy and Hold Forever
Tickers NVS V
Tags V NVS Recent Press Releases
From Motley Fool
Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
Tickers NEWS NVS
Tags Health Care Eurozone Benzinga
From Benzinga
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
Tickers ARKG NEWS NVS SDGR
Tags NVS why it's moving Earnings
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags REGN Expert Ideas LLY
From Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
Tickers BMY GILD LYEL NEWS
Tags General Briefs Downgrades
From Benzinga
Novartis Ag (NVS) Q3 2024 Earnings Call Transcript
Tickers NVS
Tags NVS Recent Press Releases Market News
From Motley Fool
Novartis Q3 Earnings Beats Expectations On Strong Sales From Key Drugs, Lifts 2024 Outlook
Tickers NEWS NVS
Tags Large Cap Market News Movers
From Benzinga
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
Tickers GLUE NEWS NVS
Tags Market News Movers Briefs
From Benzinga
3 Absurdly Cheap Stocks That Pay High Dividends
Tickers GILD MRK NVS
Tags Recent Press Releases Market News GILD
From Motley Fool
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
Tickers CTLT NEWS NVO NVS
Tags NVS M&A CTLT
From Benzinga
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
Tickers NEWS NVS SNY
Tags Equities Biotech NVS
From Benzinga
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
Tickers NVS
Tags Recent Press Releases Market News NVS
From Motley Fool
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
Tickers ALPMF ALPMY APLS NEWS
Tags Briefs General Price Target
From Benzinga
Looking Into Novartis's Recent Short Interest
Tickers NVS
Tags Short Sellers NVS BZI/SHORTHIST
From Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
Tickers ABBV NVS
Tags Recent Press Releases ABBV Market News
From Motley Fool
Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm
Tickers NEWS NVS OKUR
Tags Analyst Ratings Biotech NVS
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.